The somatomedins are GH-dependent, insulin-like peptides with metabolic and mitogenic actions for a widely variety of cell lines. Insulin and the IGFs share overlapping biological activities, which are presumably mediated through binding to specific receptors on target cell membranes. However, studies designed to characterize the method of action of these peptides, and to determine which receptor(s) mediates each metabolic and mitogenic effect, have been handicapped by the significant structural and functional homology of the peptides and their respective receptors. The development of antibodies specifically directed at each receptor has provided powerful new probes for the delineation of insulin and IGF action. To date, monoclonal and polyclonal antibodies have been generated against the human insulin, human IGF-I and rat IGF-II receptors. In this project, we will continue our efforts to evaluate the structural and functional interrelationships of the insulin, IGF-I and IGF-II receptors. Specifically, we plan to purify each receptor by detergent solubilization and affinity chromatography, and to generate and characterize anti-receptor antibodies produced by immunization with rat and human insulin, IGF-I and IGF-II receptors at various levels of purity. Specific antibodies will be developed which will immunoprecipitate each receptor, inhibit ligand binding, and/or block the """"""""effector"""""""" portion of the receptor. These antibodies will be employed, together with competitive binding and affinity cross-linking, to determine tissue and species specificity of the receptors, ontogeny of each receptor, and receptor phosphorylation and kinase activity. Receptor biosynthesis and post-translational processing will be evaluated by immunoprecipitation of cells which have been pulse-chase labeled with (35-S)-methionine following treatment with a variety of agents that interfere with glycosylation and peptide processing. Immunohistochemical studies will: 1) localize insulin and IGF receptors in various tissues, 2) determine the distribution of receptors within a cell, and 3) follow receptor processing during glycosylation, as well as """"""""up"""""""" and """"""""down"""""""" regulation. Finally, we will attempt to determine the specific roles of the insulin and IGF receptors in DNA synthesis, cell replication, amino acid transport, glucose transport, and protein synthesis in fetal and adult fibroblasts, L6 myoblasts and myotubes, leukemic lymphoblasts, pituitary cells, and IGF-II producing cell lines. It is anticipated that these studies will provide important new data on the fundamental biological functions of each of these growth factors and their receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK028229-09
Application #
3228680
Study Section
Endocrinology Study Section (END)
Project Start
1981-04-01
Project End
1992-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
9
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Rosenbloom, A L; Berg, M A; Kasatkina, E P et al. (1995) Severe growth hormone insensitivity (Laron syndrome) due to nonsense mutation of the GH receptor in brothers from Russia. J Pediatr Endocrinol Metab 8:159-65
Rosenbloom, A L; Guevara-Aguirre, J (1994) PRISMATIC case: bienvenidos a mi tierra de soledad: from poetry to molecular biology in southern Ecuador. J Clin Endocrinol Metab 79:695-702
Okajima, T; Iwashita, M; Takeda, Y et al. (1993) Inhibitory effects of insulin-like growth factor (IGF)-binding proteins-1 and -3 on IGF-activated glucose consumption in mouse BALB/c 3T3 fibroblasts. J Endocrinol 136:457-70
Marini, J C; Bordenick, S; Heavner, G et al. (1993) The growth hormone and somatomedin axis in short children with osteogenesis imperfecta. J Clin Endocrinol Metab 76:251-6
Oh, Y; Muller, H L; Lee, D Y et al. (1993) Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Endocrinology 132:1337-44
Guevara-Aguirre, J; Rosenbloom, A L; Fielder, P J et al. (1993) Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations. J Clin Endocrinol Metab 76:417-23
Adashi, E Y; Resnick, C E; Rosenfeld, R G et al. (1993) Insulin-like growth factor (IGF) binding protein-1 is an antigonadotropin: evidence that optimal follicle-stimulating hormone action in ovarian granulosa cells is contingent upon amplification by endogenously-derived IGFs. Adv Exp Med Biol 343:377-85
Oh, Y; Muller, H L; Neely, E K et al. (1993) New concepts in insulin-like growth factor receptor physiology. Growth Regul 3:113-23
Adashi, E Y; Resnick, C E; Tedeschi, C et al. (1993) A kinase-mediated regulation of granulosa cell-derived insulin-like growth factor binding proteins (IGFBPs): disparate response sensitivities of distinct IGFBP species. Endocrinology 132:1463-8
Cohen, P; Peehl, D M; Stamey, T A et al. (1993) Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 76:1031-5

Showing the most recent 10 out of 82 publications